[ad_1]
Kolkata:
The section III trial of Covaxin– the vaccine for COVID-19 — on the National Institute of Cholera and Enteric Disease (NICED) in Kolkata will begin from Wednesday, a senior official mentioned.
State Urban Development Minister Firhad Hakim (62) is prone to be the volunteer to take the primary shot of Covaxin if every little thing goes based on plan and he’s discovered to be match within the medical checks, the official of the institute mentioned on Monday.
“The phase III trials of Covaxin will be starting on December 2. We have requested some of the applicants, including (Mr) Hakim, to appear for the trials on that day. They will be administered the vaccine only after they test fit for the trials. They cannot have any comorbidities. Following satisfactory results, the shots will be administered to them,” the official mentioned.
Mr Hakim, additionally the chief of the Kolkata Municipal Corporation, had earlier expressed want to be a volunteer for the trials.
“It is a great feat that he has expressed his willingness to be a part of the prorgamme and we will be happy to enrol him. He requires to take a few screening tests, following which the next step will be decided,” the official added.
Asked whether or not the senior Trinamool Congress chief might be getting the vaccine or the placebo, he mentioned that because the section III trial of Covaxin is a double-blinded placebo- managed research, neither the volunteer nor the investigator will be capable to know who’s receiving what.
Half of the volunteers might be receiving the first- candidate vaccines, indigenously developed by Hyderabad-based Bharat Biotech and the ICMR, whereas the remainder might be given placebos, he mentioned.
Another shot might be administered to every of the volunteers after 4 weeks of the primary one.
At least 1,000 volunteers might be administered the Covaxin within the section III trials in Kolkata.
[ad_2]
Source hyperlink